^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
SPH5030
i
Other names: SPH5030, I025-A
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Shanghai Pharma
Drug class:
HER2 inhibitor
Related drugs:
22d
A Food Effect Study of SPH5030 Tablets. (clinicaltrials.gov)
P1, N=16, Completed, Shanghai Pharmaceuticals Holding Co., Ltd
New P1 trial
|
SPH5030
2years
SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors (clinicaltrials.gov)
P1, N=105, Recruiting, Shanghai Pharmaceuticals Holding Co., Ltd
New P1 trial
|
HER-2 (Human epidermal growth factor receptor 2)
|
HER-2 positive
|
SPH5030
Share via
